Literature DB >> 11690716

Hepatitis C and liver transplantation.

M Berenguer1, F X López-Labrador, T L Wright.   

Abstract

Mesh：

Year:  2001        PMID： 11690716     DOI： 10.1016/s0168-8278(01)00179-9

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  54 in total

Review 1.  Viral quasispecies evolution.

Authors:  Esteban Domingo; Julie Sheldon; Celia Perales
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

Review 2.  Recurrent hepatitis C post-transplantation: where are we now and where do we go from here? A report from the Canadian transplant hepatology workshop.

Authors:  Kymberly D S Watt; Kelly Burak; Marc Deschênes; Les Lilly; Denis Marleau; Paul Marotta; Andrew Mason; Kevork M Peltekian; Eberhard L Renner; Eric M Yoshida
Journal:  Can J Gastroenterol       Date:  2006-11       Impact factor: 3.522

3.  Intravenous interferon administered during liver transplantation is not effective in preventing hepatitis C reinfection.

Authors:  Mark W Russo; Tarun Narang; Lon Eskind; Daniel Hayes; Vincent Casingal; Preston P Purdum; John S Hanson; Will Ahrens; James Norton; Herbert Bonkovsky
Journal:  Dig Dis Sci       Date:  2013-06-29       Impact factor: 3.199

4.  Donor graft steatosis influences immunity to hepatitis C virus and allograft outcome after liver transplantation.

Authors:  Vijay Subramanian; Anil B Seetharam; Neeta Vachharajani; Venkataswarup Tiriveedhi; Nataraju Angaswamy; Sabarinathan Ramachandran; Jeffrey S Crippin; Surendra Shenoy; William C Chapman; Thalachallour Mohanakumar; Christopher D Anderson
Journal:  Transplantation       Date:  2011-12-15       Impact factor: 4.939

Review 5.  Living donor liver transplantation to patients with hepatitis C virus cirrhosis.

Authors:  Yasuhiko Sugawara; Masatoshi Makuuchi
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

6.  Impact of calcineurin inhibitors on hepatitis C recurrence after liver transplantation.

Authors:  Robin D Kim; Shugo Mizuno; John B Sorensen; Jason J Schwartz; Shiro Fujita
Journal:  Dig Dis Sci       Date:  2011-09-01       Impact factor: 3.199

7.  Patients with chronic hepatitis C express a high percentage of CD4(+)CXCR5(+) T follicular helper cells.

Authors:  Junyan Feng; Xiaoli Hu; Hui Guo; Xiguang Sun; Juan Wang; Lijun Xu; Zhenyu Jiang; Bingchuan Xu; Junqi Niu; Yanfang Jiang
Journal:  J Gastroenterol       Date:  2012-03-17       Impact factor: 7.527

Review 8.  Comparing outcomes of donation after cardiac death versus donation after brain death in liver transplant recipients with hepatitis C: a systematic review and meta-analysis.

Authors:  Malcolm Wells; Kris M Croome; Toni Janik; Roberto M Hernandez-Alejandro; Natasha M Chandok
Journal:  Can J Gastroenterol Hepatol       Date:  2013-11-28

9.  Antiviral treatment for hepatitis C virus infection after liver transplantation.

Authors:  Yasuhiko Sugawara; Sumihito Tamura; Norihiro Kokudo
Journal:  Hepat Res Treat       Date:  2010-11-01

Review 10.  Apolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature review.

Authors:  Inga Kuhlmann; Anne Marie Minihane; Patricia Huebbe; Almut Nebel; Gerald Rimbach
Journal:  Lipids Health Dis       Date:  2010-01-28       Impact factor: 3.876
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.